New Mexico Business Today
SEE OTHER BRANDS

Keeping up with business and economy news from New Mexico

APA Statement on White House Announcement on Autism

Washington, D.C., Sept. 22, 2025 (GLOBE NEWSWIRE) -- In reaction to today’s White House announcement, the American Psychiatric Association issued the following statement:

“It is essential that the administration prioritizes evidence-based support for individuals on the autism spectrum and invests in long-term comprehensive research about the disorder.

Vaccines do not cause autism. Claims of any such association have been repeatedly discredited in peer reviewed studies.

Autism is a complex disorder, and it is incorrect to imply that a handful of studies have established causation. A strong base of evidence shows that acetaminophen, when taken as directed, is safe for use during pregnancy. Any decisions around a course of treatment should be determined by a patient and their doctor.

Leucovorin (folinic acid) has not been a recommended treatment for autism. It will require many more years of research before we know if leucovorin is an appropriate treatment for individuals with autism.

Autism spectrum disorders exist on a spectrum of neurodiversity. The country must focus its resources on expanding access to care and to building the evidence-base for future treatments.”

American Psychiatric Association
The American Psychiatric Association, founded in 1844, is the oldest medical association in the country. The APA is also the largest psychiatric association in the world with more than 39,200 physician members specializing in the diagnosis, treatment, prevention and research of mental illness. APA’s vision is to ensure access to quality psychiatric diagnosis and treatment. For more information, please visit www.psychiatry.org.


Erin Connors
American Psychiatric Association
202-609-7113
econnors@psych.org

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions